Vaccine Therapy in Treating Patients With Breast Cancer
Biological: GP2 peptide + GM-CSF vaccine
Biological: GM-CSF (sargramostim)
Biological: AE37 + GM-CSF vaccine
http://www.clinicaltrials.gov/ct2/sh...and+gp2&rank=1
Above is the link for one of the vaccine trials. SandraGA, ElizabethTX, myself and others have participated in this trial. It is still in Phase II and they have added booster shots so you would receive additional treatment to prevent cancer for approximately 2 1/2 years.
Once the phase II is over, the sponsoring companies will target the lower Her2 expressions in Phase III, as it is an "untapped" market (currently combined in with the triple negative group).
It is an excellent opportunity for someone, as interim reports show a statistical advantage in the vaccine arm. Even if you are in the control arm you will receive a small amount of the vaccine twice to assist in scientific research.
If this clinical trial won't work for you the Mayo Clinic has an vaccine trial, but enrollment is within 90 days of finishing Herceptin. The link above is for enrollment within 6 months.
If you can travel, and you are concerned about recurrence, and you want to help improve standard of care for future breast cancer patients - please contact the clinical trial nurse for more information.
You can also check out the latest trials on clinicaltrials.gov
It will take about another 5 - 7 years for approval, but wouldn't it be great if we could receive a vaccine shot after treatment that gives additional protection from recurrence?